BridgeBio Pharma (BBIO) Revenue Growth (1y) (2020 - 2026)
BridgeBio Pharma (BBIO) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 35.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | 66.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.78% |
| Dec 31, 2025 | 2,521.18% |
| Sep 30, 2025 | 4,318.01% |
| Jun 30, 2025 | 4,999.86% |
| Mar 31, 2025 | -44.76% |
| Dec 31, 2024 | 237.08% |
| Sep 30, 2024 | -33.22% |
| Jun 30, 2024 | 32.11% |
| Mar 31, 2024 | 11,461.88% |
| Dec 31, 2023 | -6.68% |
| Sep 30, 2023 | 1,110.36% |
| Jun 30, 2023 | -97.77% |
| Mar 31, 2023 | 7.79% |
| Dec 31, 2022 | -81.30% |
| Sep 30, 2022 | -85.58% |
| Jun 30, 2022 | 36.51% |
| Mar 31, 2022 | 266.67% |
| Dec 31, 2021 | 8,096.72% |
| Sep 30, 2021 | -71.16% |
| Sep 30, 2020 | -69.56% |